TLX591-Tx ProstACT SELECT Study Published in Cancers Journal
Go back to TLX591-Tx ProstACT SELECT Study Published in Cancers Journal| TRANS-LUX CORPORATION (NASDAQ: TLX) | Delayed: 10.32 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.32 | 52 Week High | $2.18 | |||
| Open | $10.32 | 52 Week Low | $0.30 | |||
| Day High | $10.32 | P/E | N/A | |||
| Day Low | $10.32 | EPS | $-3.32 | |||
| Volume | 1,481 | |||||
| TRANS-LUX CORPORATION (NASDAQ: TLX) | Delayed: 10.32 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.32 | 52 Week High | $2.18 | |||
| Open | $10.32 | 52 Week Low | $0.30 | |||
| Day High | $10.32 | P/E | N/A | |||
| Day Low | $10.32 | EPS | $-3.32 | |||
| Volume | 1,481 | |||||

